Tempol blunts afferent arteriolar remodeling in chronic nitric oxide-deficient hypertension without normalizing blood pressure

References

• Kawabe K, Watanabe TX, Shiono K, Sokabe H. Influence on blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn Heart J 1978;19:886–94
   PubMedGoogle Scholar
• Rettig R, Folberth C, Kopf D, et al. Role of the kidney in the pathogenesis of primary hypertension. Clin Exp Hypertens 1990;12:957–1002
   Web of Science ®Google Scholar
• Rettig R, Folberth CG, Stauss H, et al. Hypertension in rats induced by renal grafts from renovascular hypertensive donors. Hypertension 1990;15:429–35
   PubMed Web of Science ®Google Scholar
• New DI, Chesser AM, Thuraisingham RC, Yaqoob MM. Structural remodeling of resistance arteries in uremic hypertension. Kidney Int 2004;65:1818–25
   PubMed Web of Science ®Google Scholar
• Lau C, Sudbury I, Thomson M, et al. Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes. Am J Physiol Regul Integr Comp Physiol 2009;296:R1761–70
   PubMed Web of Science ®Google Scholar
• Eftekhari A, Mathiassen ON, Buus NH, et al. Changes in blood pressure and systemic vascular resistance do not predict microvascular structure during treatment of mild essential hypertension. J Hypertens 2012;30:794–801
   PubMed Web of Science ®Google Scholar
• Masulli M, Mancini M, Liuzzi R, et al. Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy. Nutr Metab Cardiovasc Dis 2009;19:358–64
   PubMed Web of Science ®Google Scholar
• Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens 2000;13:810–18
   PubMed Web of Science ®Google Scholar
• Kimura K, Tojo A, Matsuoka H, Sugimoto T. Renal arteriolar diameters in spontaneously hypertensive rats. Vascular cast study. Hypertension 1991;18:101–10
   PubMed Web of Science ®Google Scholar
• Gattone II VH, Evan AP, Willis LR, Luft FC. Renal afferent arteriole in the spontaneously hypertensive rat. Hypertension 1983;5:8–16
   PubMed Web of Science ®Google Scholar
• Skov K, Mulvany M, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 1992;20:821–7
   PubMed Web of Science ®Google Scholar
• Anderson WP, Kett MM, Evans RG, Alcorn D. Pre-glomerular structural changes in the renal vasculature in hypertension. Blood Pressure 1995;2:74–80
   Google Scholar
• Zou LX, Imig JD, Von Thun AM, et al. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II infused rats. Hypertension 1996;28:669–77
   PubMed Web of Science ®Google Scholar
• Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968–72
   PubMed Web of Science ®Google Scholar
• Park J, Schiffrin E. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 2001;19:921–30
   PubMed Web of Science ®Google Scholar
• Fan Z-D, Zhang L, Shi Z, et al. Artificial microRNA interference targeting AT1a receptors in paraventricular nucleus attenuates hypertension in rats. Gene Ther 2012;19:810–17
   PubMed Web of Science ®Google Scholar
• Joo Turoni CM, Reynoso HA, Marañón RO, et al. Structural changes in the renal vasculature in streptozotocin-induced diabetic rats without hypertension. Nephron Physiol 2005;99:50–7
   Google Scholar
• Miatello R, Cruzado M, Risler N. Mechanisms of cardiovascular changes in an experimental model of syndrome X and pharmacological intervention on the renin-angiotensin system. Curr Vasc Pharmacol 2004;2:371–7
   PubMedGoogle Scholar
• Kurose I, Wolf R, Grisham MB, et al. Microvascular responses to inhibition of nitric oxide production. Role of active oxidants. Circ Res 1995:76:30–9
   Google Scholar
• Zhou MS, Schulman IH, Raij L. Nitric oxide, angiotensin II, and hypertension. Semin Nephrol 2004;24:366–78
   PubMed Web of Science ®Google Scholar
• Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 1998;101:731–6
   PubMed Web of Science ®Google Scholar
• Mattson DL, Lu S, Nakanishi K, et al. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol 1994;266:H1918–26
   PubMed Web of Science ®Google Scholar
• Bouriquet N, Dupont M, Herizi A, et al. Preglomerular sudanophilia in L-NAME hypertensive rats. Involvement of endothelin. Hypertension 1996;27:382–91
   PubMed Web of Science ®Google Scholar
• Ribeiro MO, Antunes E, de Nucci G, et al. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 1992;20:298–303
   PubMed Web of Science ®Google Scholar
• Goligorsky MS, Brodsky SV, Noiri E. NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. Seminars in Nephrology 2004;24:316–23
   PubMed Web of Science ®Google Scholar
• De Bruno MP, Turoni CMJ, Marañón RO, et al. Structural changes in the kidney induced by coarctation hypertension. Clin Exp Hypertens 2001;23:501–11
   PubMed Web of Science ®Google Scholar
• Skalli O, Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787–96
   PubMed Web of Science ®Google Scholar
• Brand M, Lamandé N, Sigmund CD, et al. Angiotensinogen modulates renal vasculature growth. Hypertension 2006;47:1067–74
   PubMed Web of Science ®Google Scholar
• Qujeq D, Habibinudeh M, Daylmkatoli H, Rezvani T. Malondialdehyde and carbonyl contents in the erythrocytes of streptozotocin-induced diabetic rats. Int J Diabetes Metabolism 2005;13:96–8
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75
   PubMed Web of Science ®Google Scholar
• Chander V, Chopra K. Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats. J Surg Res 2005;128:132–9
   PubMed Web of Science ®Google Scholar
• Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994;330:1431--8
   Google Scholar
• Mulvany MJ. Vascular remodeling of resistance vessels: can we define this? Cardiovascular Research 1999;41:9–13
   PubMed Web of Science ®Google Scholar
• Mulvany MJ, Baumbach GL, Aalkjaer C, et al. Vascular remodeling. Hypertension 1996;28:505–6
   PubMed Web of Science ®Google Scholar
• Pires PW, Deutsch C, McClain JL, et al. Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats. Microvasc Res 2010;80:445–52
   PubMed Web of Science ®Google Scholar
• Carlström M, Lai EY, Ma Z, et al. Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability. Hypertension 2010;56:907–13
   PubMed Web of Science ®Google Scholar